|
|
Bioinformatics News
|
Another Look Finds Promising Proteomics Test is Not Biologically Plausible
Go to the Web site
February 15, 2005
In a new study, researchers present a cautionary tale about what may go wrong when using the fledgling science of proteomics to devise a diagnostic test for cancer. M. D. Anderson Cancer Center researchers detail why an experimental test intended to identify early ovarian cancer from a small sample of blood is unlikely to lead to a reliable clinical test right away. Checks of the data supportting the test's effectiveness indicate that claims about the experimental protein-based assay are not biologically plausible.
|
Microsoft Collaborates With Leading Doctors and Scientists, Using Advanced Machine-Learning Techniques to Optimize HIV Vaccines
Go to the Web site
February 23, 2005
Microsoft Research has pioneered promising new ways to combat one of humankind's most deadly viruses withadvanced software typically used to analyze large computer databases andcomplex digital images, or to separate spam from legitimate e-mail.
|
Ciphergen Signs Collaboration Agreement with The University of Texas M. D. Anderson Cancer Center to further the Discovery, Validation, and Characterization of Ovarian Cancer Biomarkers
Go to the Web site
February 15, 2005
Ciphergen Diagnostics, a division of Ciphergen Biosystems, Inc. (Nasdaq: CIPH), announced today that it has signed a research and license agreement with The University of Texas M. D. Anderson Cancer Center to utilize Ciphergen's ProteinChip System and associated bioinformatics suites to further their ongoing research in ovarian cancer. M. D. Anderson is a major referral center for patients with ovarian cancer and is a National Cancer Institute-designated Comprehensive Cancer Center.
|
|
|
